Outcome and prognostic factors in 110 consecutive patients with primary uterine leiomyosarcoma: A Rare Cancer Network study.

Date publication

décembre 2017

Journal

Chinese journal of cancer research = Chung-kuo yen cheng yen chiu

Auteurs

Membres identifiés du Cancéropôle Est :
Dr CHAN Susan

Tous les auteurs :
Pellanda AF, De Bari B, Deniaud-Alexandre E, Krengli M, Van Houtte P, Richetti A, Villà S, Goldberg H, Szutowicz-Zielińska E, Bolla M, Rutten H, Van Eijkeren M, Poortmans P, Henke G, Anacak Y, Chan S, Landmann C, Kirkove C, Scandolaro L, Bernier J, Mirimanoff RO, Ozsahin M

Lien Pubmed

http://www.ncbi.nlm.nih.gov/pubmed/29353974

Résumé

Primary uterine leiomyosarcomas (ULMS) are rare, and the optimal treatment is controversial. We aimed to assess the outcome and prognostic factors in a multicenter population of women treated for primary ULMS.

Référence

Chin. J. Cancer Res.. 2017 Dec;29(6):521-532